|
Revenue
|
|
$130.6m
|
$169.7m
|
$229.1m
|
$261.2m
|
$297.6m
|
$327.5m
|
$344.6m
|
|
Cost of revenue
|
|
$64.9m
|
$76.9m
|
$106.2m
|
$126.2m
|
$145.1m
|
$156.6m
|
$166.6m
|
|
Gross profit
|
|
$65.7m
|
$92.8m
|
$123.0m
|
$135.1m
|
$152.5m
|
$170.9m
|
$178.1m
|
|
Research and development
|
|
$25.0m
|
$36.6m
|
$55.3m
|
$72.0m
|
$71.6m
|
$68.1m
|
$69.4m
|
|
Total operating expenses
|
|
$79.6m
|
$99.6m
|
$178.4m
|
$243.7m
|
$229.4m
|
$218.8m
|
$212.1m
|
|
Sales and marketing
|
|
$36.6m
|
$41.1m
|
$70.2m
|
$87.7m
|
$88.4m
|
$86.4m
|
$83.1m
|
|
General and administrative
|
|
$17.9m
|
$21.9m
|
$52.9m
|
$84.0m
|
$69.3m
|
$64.3m
|
$59.6m
|
|
Operating profit (loss)
|
|
($13.9m)
|
($6.8m)
|
($55.4m)
|
($108.6m)
|
($76.8m)
|
($47.9m)
|
($34.0m)
|
|
Profit (loss) before income taxes
|
|
($13.7m)
|
($10.3m)
|
($177.3m)
|
($97.9m)
|
($53.2m)
|
($28.5m)
|
($21.2m)
|
|
Provision for (benefit from) income taxes
|
|
$475k
|
$1.1m
|
$1.6m
|
$6.0m
|
$5.8m
|
$6.4m
|
$6.4m
|
|
Net profit (loss)
|
|
($14.2m)
|
($11.3m)
|
($178.9m)
|
($104.0m)
|
($59.0m)
|
($34.9m)
|
($27.6m)
|
|
Net profit (loss) per share attributable to ordinary shareholders, basic (in dollars per share)
|
|
($2)
|
($2)
|
($5)
|
($1)
|
($1)
|
($0)
|
($0)
|
|
Net profit (loss) per share attributable to ordinary shareholders, diluted (in dollars per share)
|
|
($2)
|
($2)
|
($5)
|
($1)
|
($1)
|
($0)
|
($0)
|
|
Weighted-average shares used in computing net profit (loss) per share attributable to ordinary shareholders, basic (in shares)
|
|
($1)
|
($0)
|
($2)
|
($1)
|
($0)
|
($0)
|
($0)
|
|
Weighted-average shares used in computing net profit (loss) per share attributable to ordinary shareholders, diluted (in shares)
|
|
($1)
|
($0)
|
($2)
|
($1)
|
($0)
|
($0)
|
($0)
|
|
Interest income (expense), net
|
|
$53k
|
$145k
|
$591k
|
$10.2m
|
$22.8m
|
$20.2m
|
$13.5m
|
|
Other income (expense), net
|
|
$122k
|
($3.6m)
|
($122.5m)
|
$505k
|
$837k
|
($818k)
|
($637k)
|